Israel Pacemaker Market to be Dominated by the Implantable Segment by 2028
Growing cases of cardiovascular
conditions such as arrhythmias and bradycardia is expected to drive Israel
pacemaker market in the forecast period, 2024-2028.
According to TechSci Research
report, “Israel Pacemaker Market –Industry Size, Share, Trends, Opportunity,
and Forecast, 2018-2028F”, the Israel pacemaker market is anticipated to
grow at a steady rate in the forecast period. This can be
attributed to the increased prevalence of cardiovascular diseases in the
country, growing aged population susceptible to risk of non-communicable
diseases along with the technological advancement in the pacemakers.
In Israel, cardiovascular
illnesses are the main cause of death, and risk factors like smoking, high
blood pressure, and diabetes are very common. To address these diseases, there
is an increasing demand for cardiac interventions, such as pacemakers and is
thus, anticipated to propel the demand for Israel pacemaker market in the
forecast period. The pacemaker industry is constantly evolving, with new technologies
and advancements being developed that enhance the safety, efficacy, and
functionality of pacemakers. These advancements are leading to the increased
demand for pacemakers as patients and healthcare providers seek out the latest
and advanced devices. The advancements in pacemaker, such as, the development
of MRI compatible pacemakers and Bluetooth enrolled pacemakers are improving
the efficiency as well as the compatibility of pacemakers with providing more
ease and efficiency for monitoring the health conditions of the patient. These
factors are contributing to the growth of Israel pacemaker market.
Moreover, the growing awareness
among the public and healthcare providers in Israel regarding the pacemakers
and their benefits in managing cardiac conditions has led to greater demand for
pacemakers and other cardiac devices.
However, pacemakers are
expensive medical devices, and this can be a barrier for patients who cannot
afford them. In Israel, where healthcare costs are high, the cost of pacemakers
may be a concern for some patients. This factor can show a negative impact on
the growth of Israel pacemaker market.
Browse over XX Market Data
Figures spread through XX Pages and an
in-depth TOC on "Israel Pacemaker Market”
Based on application, the market
is segmented into arrythmias, congestive heart failure, and others. The
arrythmias segment is dominating the market in 2022 and is expected to hold the
highest market share in the forecast period. This is on account of increased
adoption of lifestyle patterns such as alcohol consumption, smoking, and
obesity.
Based on product type, the
market is segmented into conventional and MRI compatible. The MRI compatible
segment dominated in 2022 and is expected to hold the highest share in the
forecast period. This is due to the increase in demand for MRI compatible
pacemakers, as most patient using implantable pacemakers must undergo MRI
frequently and thus, can create issue’s when used in patient with conventional
pacemakers. Hence, the segment is acquiring the highest growth due to increased
MRI diagnosis in patients suffering cardiac conditions such as arrythmias.
Based on end users, the market
is further segmented into hospitals, cardiac care centers, and ambulatory
surgical centers. The hospitals segment dominated in 2022 and is expected to
hold the highest share in the coming years. This is attributed to the factors
such as more patient’s admissions compared to the cardiac centers and other
facilities. Moreover, these facilities additionally provide reimbursements for
procedures, which is causing the market to flourish.
Major companies operating in the
Israel pacemaker market are:
- MEDTRONIC ISRAEL
- BOSTON SCIENTIFIC ISRAEL LTD
- Israel Abbott
- Edwards Lifesciences Israel Ltd.
- Johnson and Johnson Israel
Download Free Sample Report
Customers can also request for
10% free customization on this report.
“The Israel pacemaker market
growth is attributed on the account of rising prevalence of cardiovascular
diseases in the country and rising risk of non-communicable diseases. Besides,
investment in research & development activities for the expansion of technology
advancement in the pacemakers are further expected to support the growth of
Israel pacemaker market” said Mr. Karan Chechi, Research Director with TechSci
Research, a research based global management consulting firm.
“Israel Pacemaker Market, By Type
(Implantable, External), By Technology (Single Chamber, Dual Chamber, and
Biventricular Chamber), By Product Type (Conventional, MRI Compatible), By
Application (Arrythmias, Congestive Heart Failure, and Others), By End User
(Hospitals, Cardiac Care Centers, and Ambulatory Surgical Centers), By Region,
Competition, Forecast and Opportunities, 2028”, has
evaluated the future growth potential of Israel pacemaker market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Israel pacemaker market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com